41-year-old Man With Pulmonary Embolism 5 Months After Covid19
Authors/Creators
- 1. Internal Medicine Resident PGY3, Department of Internal Medicine, Detroit Medical Centre/Wayne State University, USA
- 2. Internal Medicine Resident PGY2, Department of Internal Medicine, Detroit Medical Centre/Wayne State University, USA
- 3. Professor of Medicine, Department of Pulmonary Critical Care & Sleep Division, Wayne State University, USA
Description
Abstract
Background: Hypercoagulation is one of the striking features of COVID-19. Patients hospitalized with COVID-19 are at high risk for venous thromboembolism. However, it is unknown if the risk for venous thromboembolism persists after discharge.
Case Summary: We report a case with pulmonary embolism 5 months after COVID-19. No risk factors for venous thrombosis have been identified.
Conclusion: In COVID-19 related hospitalization, large studies are needed to identify the risk of venous thromboembolism after discharge.
Introduction
Coronavirus disease 2019 (COVID-19) is continuing its spread with more than 30 million confirmed cases around the globe. To date, the long-term sequelae of COVID-19 is unknown as we are still in the first months of the pandemic. Our experience with other coronaviruses suggests the potential for ongoing organ damage [1] and this might be applicable to COVID-19. With this huge number of infected patients, the long-term impact of COVID-19 will cause a significant burden on health care system. Hypercoagulation is one of the remarkable features of COVID-19. Patients who are hospitalized with COVID-19 are at increased risk for venous thromboembolism. Incidence of venous thromboembolism in patients with COVID-19 is 20 to 40 percent in the intensive care unit (ICU) [2-4] and 3 to 8 percent in non-ICU [5,6] even when prophylactic anticoagulation is used. However, it is unknown if risk for venous thromboembolism continues after discharge. We report a case without risk factors for venous thromboembolism, developed pulmonary embolism 5 months after COVID-19. This case raises concern about the possibility of prolonged risk for venous thromboembolism in COVID-19.
Notes
Files
IJCMC-3-166.pdf
Additional details
Related works
- Is published in
- Journal article: https://www.boffinaccess.com/clinical-and-medical-cases/41-year-old-3-166 (URL)
- Journal article: https://www.boffinaccess.com/clinical-and-medical-cases/41-year-old-3-166/IJCMC-3-166.pdf (URL)
References
- 1. Hui DS, Wong KT, Ko FW, Tam LS, Chan DP, et al. The 1-year impactof severe acute respiratory syndrome on pulmonary function,exercise capacity, and quality of life in a cohort of survivors. Chest2005;128:2247.
- 2. Helms J, Tacquard C, Severac F, Leonard-Lorant I,Ohana M, etal. High risk of thrombosis in patients with severe SARS-CoV-2infection: a multicenter prospective cohort study. Intensive CareMed. 2020 Jun;46(6):1089-1098.
- 3. Klok FA, Kruip MJHA, van der Meer NJM, M S Arbous, D A M PJ Gommers, et al. Incidence of thrombotic complications incritically ill ICU patients with COVID-19. Thromb Res. 2020Jul;191:145-147.
- 4. Bilaloglu S, Aphinyanaphongs Y, Jones S, Iturrate E, Hochman J, etal. Thrombosis in Hospitalized Patients With COVID-19 in a New YorkCity Health System. JAMA. 2020 Aug 25;324(8):799-801.
- 5. Middeldorp S, Coppens M, van Haaps TF, Foppen M, Vlaar AP, et al.Incidence of venous thromboembolism in hospitalized patientswith COVID-19. J Thromb Haemost. 2020 Aug;18(8):1995-2002.
- 6. Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, et al. Venous and arterial thromboembolic complications in COVID-19patients admitted to an academic hospital in Milan, Italy. ThrombRes. 2020 Jul;191:9-14.
- 7. Beckman M, Nyrén S, Kistner A. A case-report of widespreadpulmonary embolism in a middle-aged male seven weeksafter asymptomatic suspected COVID 19 infection. Thromb J.2020;18:19.
- 8. Di Tano G, Moschini L, Loffi M, Testa S, Danzi GB. LatePulmonary Embolism after COVID-19 Pneumonia despiteAdequate Rivaroxaban Treatment. Eur J Case Rep Intern Med.2020;7(7):001790.